These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 2354460

  • 1. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H, Brownstein BH, Gurfel D, Wu SH, Rosner MC, Golomb HM.
    Cancer Res; 1990 Jul 01; 50(13):4111-20. PubMed ID: 2354460
    [Abstract] [Full Text] [Related]

  • 2. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
    Genot E, Valentine MA, Degos L, Sigaux F, Kolb JP.
    J Immunol; 1991 Feb 01; 146(3):870-8. PubMed ID: 1703183
    [Abstract] [Full Text] [Related]

  • 3. Interferon-induced surface alterations in hairy cells. A review.
    Gamliel H, Gurfel D, Wu SH, Golomb HM.
    Scanning Microsc; 1988 Mar 01; 2(1):485-92. PubMed ID: 3368772
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 Mar 01; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 5. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
    Liberati AM, Schippa M, Portuesi MG, Grazia Proietti M, De Angelis V, Ferrajoli A, Cinieri S, Di Clemente F, Palmisano L, Berruto P.
    Haematologica; 1991 Mar 01; 76(5):375-82. PubMed ID: 1806440
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS, Banez M, Okun E, Morton DL, Irie RF.
    Cancer Res; 1991 Apr 15; 51(8):2002-8. PubMed ID: 1901239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of the B8.7 antigen on hairy cells and relation with the LMW-BCGF response.
    Génot E, Leprince C, Richard Y, Petit-Koskas E, Falcoff E, Galanaud P, Sigaux F, Kolb JP.
    Leukemia; 1989 May 15; 3(5):367-72. PubMed ID: 2785622
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
    Greiner JW, Fisher PB, Pestka S, Schlom J.
    Cancer Res; 1986 Oct 15; 46(10):4984-90. PubMed ID: 2944575
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S, Gamliel H, Golomb HM.
    Cancer Res; 1992 Mar 01; 52(5):1056-66. PubMed ID: 1737364
    [Abstract] [Full Text] [Related]

  • 12. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-alpha in vitro.
    Schwarzmeier JD, Hilgarth M, Nguyen ST, Shehata M, Gruber G, Spittler A, Willheim M, Boltz-Nitulescu G, Höcker P, Berger R.
    Cancer Res; 1996 Oct 15; 56(20):4679-85. PubMed ID: 8840984
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-alpha and B-cell growth factor induce leukemic hairy cells to proliferate in vitro.
    Trentin L, Zambello R, Pizzolo G, Vinante F, Ambrosetti A, Chisesi T, Vespignani M, Feruglio C, Adami F, Agostini C.
    Cancer Detect Prev; 1991 Oct 15; 15(5):385-90. PubMed ID: 1751949
    [Abstract] [Full Text] [Related]

  • 14. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
    Shehata M, Schwarzmeier JD, Nguyen ST, Hilgarth M, Berger R, Hubmann R, Kickmaier S, Decker T.
    Cancer Res; 2000 Oct 01; 60(19):5420-6. PubMed ID: 11034083
    [Abstract] [Full Text] [Related]

  • 15. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
    Genot E, Billard C, Sigaux F, Mathiot C, Degos L, Falcoff E, Kolb JP.
    Leukemia; 1987 Aug 01; 1(8):590-6. PubMed ID: 2444836
    [Abstract] [Full Text] [Related]

  • 16. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB, Hermo H, Solowey WE, Dietrich MC, Edwalds GM, Weinstein IB, Langer JA, Pestka S, Giacomini P, Kusama M.
    Anticancer Res; 1986 Aug 01; 6(4):765-74. PubMed ID: 2944474
    [Abstract] [Full Text] [Related]

  • 17. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters.
    Hiraoka A, Golomb HM.
    J Biol Response Mod; 1986 Jun 01; 5(3):270-81. PubMed ID: 3723140
    [Abstract] [Full Text] [Related]

  • 18. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
    Mantovani G, Astara G, Curreli L, Lai P, Turnu E, Locci F, Lantini MS, Cossu M, Riva A, Del Giacco GS.
    Haematologica; 1992 Jun 01; 77(4):326-35. PubMed ID: 1427443
    [Abstract] [Full Text] [Related]

  • 19. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
    Genot E, Sarfati M, Sigaux F, Petit-Koskas E, Billard C, Mathiot C, Falcoff E, Delespesse G, Kolb JP.
    Blood; 1989 Nov 15; 74(7):2455-63. PubMed ID: 2529929
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
    Spiro RC, Sairenji T, Humphreys RE.
    J Immunol; 1985 May 15; 134(5):3539-49. PubMed ID: 3856614
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.